Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Roquefort Thera (ROQ)

Price 7.00p on 29-03-2024 at 15:00:42
Change 0.00p 0%
Buy 7.50p
Sell 6.50p
Buy / Sell ROQ Shares
Last Trade: -
Day's Volume: 0
Last Close: 7.00p
Open: 0.00p
ISIN: GB00BMDQ2T15
Day's Range 0.00p - 0.00p
52wk Range: 5.90p - 9.25p
Market Capitalisation: £9m
VWAP: 0.00p
Shares in Issue: 129m

Recent Trades History Roquefort Thera (ROQ)

Buy/Sell Volume Trade Prc Trade Type Trade Time

Share Price History for Roquefort Thera

Time period:
to
Date Open High Low Close Volume

Share News for Roquefort Thera

Roquefort celebrates "significant milestones" in cancer research

11th Mar 2024 11:12

(Alliance News) - Roquefort Therapeutics PLC on Monday reported progress in cancer research under two of its medicine development programmes. Read More

IN BRIEF: Roquefort hails further MK studies, licence talks continue

6th Feb 2024 16:50

Roquefort Therapeutics PLC - London-based biotechnology company, focused on developing medicines for hard-to-treat cancers - Says it has continued studies on its MK cells in validated models of natural killer (NK) cell activation and cytotoxicity, showing an anti-cancer effect in leukaemia with superior efficacy to NK cells alone. Confirms that MK cells activate NK cells. Read More

Roquefort Therapeutics MK cell programme shows positive results

6th Nov 2023 12:01

(Alliance News) - Roquefort Therapeutics PLC on Monday said its Mesodermal Killer cell programme has reached a "significant" milestone. Read More

EARNINGS: Biome loss widens; Amicorp focused on growth post-IPO

27th Sep 2023 15:43

(Alliance News) - The following is a round-up of earnings of London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

Roquefort files patent application for mRNA and RNA therapies

14th Aug 2023 11:07

(Alliance News) - Roquefort Therapeutics PLC on Monday said it has filed an international phase PCT patent for its anti-cancer mRNA and RNA oligonucleotide therapies. Read More

FTSE 100 Latest
Value7,952.62
Change0.00

Login to your account

Forgot Password?

Not Registered